MRI perfusion
Devicecontrast-enhanced MR imaging including perfusion weighted imaging (PWI)
NCT Number: NCT02694406
As ovarian cancer is characterized by an anarchic neovascularization resulting in a wide number of immature microvessels. These vessels are characterized by a lack of coverage by pericytes and the higher expression of one of the receptors of Vascular Endothelial Growth Factor on both endothelial and epithelial cells of ovarian cystadenocarcinomas. These physio pathogenic characteristics have been demonstrated to be in line with variations of MR perfusion parameters.
Unlike many lesions that occur in other parts of the body, biopsy should not be performed in adnexal masses that demonstrate no evidence of peritoneal disease because it may cause spillage of cystic contents, potentially leading to iatrogenic up-staging of what may have been a malignant tumor that was limited.
Looking for future studies?
Notify MeFemale
Observational
Ahmed Abbas, Assiut, Cairo Governorate, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
contrast-enhanced MR imaging including perfusion weighted imaging (PWI)
Time frame: 2 weeks
Assiut University
Other
Added Value of MRI Perfusion in Evaluation of Complex Adnexal Masses
Acronym: MRI-CAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03970655
Chronic Rhinosinusitis (Diagnosis), Disease
Gainesville, Florida, United States
View Trial DetailsNCT07731217
Asthma, Asthma (Diagnosis)
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02328963
Cytomegalovirus Infection, Cytomegalovirus Infections
Bordeaux, France
View Trial DetailsNCT05468619
DNA Virus Infections, Disease
Birmingham, Alabama, United States
View Trial Details